You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
McKesson
Moodys
AstraZeneca
Dow

Last Updated: September 24, 2023

Xgen Pharms Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for XGEN PHARMS, and what generic and branded alternatives to XGEN PHARMS drugs are available?

XGEN PHARMS has twenty approved drugs.



Summary for Xgen Pharms
US Patents:0
Tradenames:19
Ingredients:19
NDAs:20

Drugs and US Patents for Xgen Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xgen Pharms FOLIC ACID folic acid INJECTABLE;INJECTION 202522-001 Nov 6, 2019 AP RX No No ⤷  Try a Trial ⤷  Try a Trial
Xgen Pharms CYCLOPHOSPHAMIDE cyclophosphamide INJECTABLE;INJECTION 211757-001 Oct 18, 2022 AP RX No No ⤷  Try a Trial ⤷  Try a Trial
Xgen Pharms TOBRAMYCIN SULFATE tobramycin sulfate INJECTABLE;INJECTION 065013-001 Aug 17, 2001 AP RX No Yes ⤷  Try a Trial ⤷  Try a Trial
Xgen Pharms POLYMYXIN B SULFATE polymyxin b sulfate INJECTABLE;INJECTION 063000-001 Sep 30, 1994 AP RX No No ⤷  Try a Trial ⤷  Try a Trial
Xgen Pharms AMPHOTERICIN B amphotericin b INJECTABLE;INJECTION 063206-001 Apr 29, 1992 RX No Yes ⤷  Try a Trial ⤷  Try a Trial
Xgen Pharms CLONIDINE HYDROCHLORIDE clonidine hydrochloride INJECTABLE;INJECTION 203167-002 Oct 29, 2013 AP RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Medtronic
Express Scripts
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.